The VEST External Support for Saphenous Vein Grafts in Coronary Surgery: A Review of Randomized Clinical Trials

Saphenous vein grafts (SVGs) are the most frequently used conduits in coronary artery bypass grafting (CABG), but their higher rate of occlusion compared to arterial conduits remains a concern. Previous studies have shown that SVG failure is mainly driven by intimal hyperplasia, an adaptative respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Soletti, Giovanni Jr., Dell’Aquila, Michele, Harik, Lamia, Cancelli, Gianmarco, Alzghari, Talal, Perezgrovas-Olaria, Roberto, Dimagli, Arnaldo, An, Kevin R., Leith, Jordan, Rossi, Camilla Sofia, Barile, Christopher F., Demetres, Michelle, Lau, Christopher, Girardi, Leonard N., Gaudino, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672571/
https://www.ncbi.nlm.nih.gov/pubmed/37998511
http://dx.doi.org/10.3390/jcdd10110453
Descripción
Sumario:Saphenous vein grafts (SVGs) are the most frequently used conduits in coronary artery bypass grafting (CABG), but their higher rate of occlusion compared to arterial conduits remains a concern. Previous studies have shown that SVG failure is mainly driven by intimal hyperplasia, an adaptative response to higher pressures of the arterial circulation. The VEST(TM) device (Vascular Graft Solutions, Tel Aviv, Israel), an external support designed to mitigate intimal hyperplasia in SVGs, has been tested in few clinical trials (RCTs). Herein, we descriptively evaluated the randomized evidence on the VEST device.

Ejemplares similares